Nuveen Asset Management, LLC Alkermes Plc. Transaction History
Nuveen Asset Management, LLC
- $329 Billion
- Q1 2024
A detailed history of Nuveen Asset Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,251,299 shares of ALKS stock, worth $29.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,251,299
Previous 1,965,213
36.33%
Holding current value
$29.3 Million
Previous $54.5 Million
37.87%
% of portfolio
0.01%
Previous 0.02%
Shares
23 transactions
Others Institutions Holding ALKS
# of Institutions
358Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$683 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$472 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$348 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$211 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$195 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.84B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...